MarketInOut Stock Screener Log In | Sign Up

bioAffinity Technologies Inc

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 11/17/2026 16:00
bioAffinity Technologies Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization4 mln
Float1.81 mln
Earnings Date11/13/2026

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-3.4
Reliable

Relative Strength

4 / 100
Severely lagging

Debt / Equity

0.38
Low leverage

Pre-Tax Margin

-279%
Severely loss-making

ROE

-280
Deeply negative

Business Description

bioAffinity Technologies is a San Antonio-based company focused on catching lung cancer early, before it becomes harder to treat. Their main product, CyPath Lung, examines a patient's mucus sample to identify cells that suggest the presence of a lung tumor, all without the need for invasive procedures. Founded in 2014, the company combines laboratory services with ongoing research to improve how lung diseases are detected and understood.

Key Fundamentals

EPS-40.37
ROE-280
RPS11.94
ROIC-276
ROA-169
Interest Cover-271
EBITDA, mln-14.99
EV / EBITDA-0.20
EV / EBIT-0.19
Revenue, mln5.53
EV / Revenue0.53

Quote Details

Last 1.93
Change -0.07 (-3.5%)
Open 1.99
Volume 67,866
Turnover 130,981
Average Volume 88,480

Financial Ratios

Pre-Tax Profit Margin-279
Leverage Ratio1.93
Current Ratio1.51
Price / Book0.50
Price / Tangible Book1.07
Debt / Equity0.38
Price / Sales0.14

Financial Strength

Altman Z-Score-20.09
Piotroski F-Score 3 / 9
Beneish M-Score-3.4
Short Ratio0.03
Short % of Float4.18

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -19.25% 8 / 100   
1 Month -45.01% 6 / 100   
2 Months -72.78% 5 / 100   
6 Months -92.43% 2 / 100   
1 Year -93.01% 5 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog